IgA deposits in an allograft from a patient with subclinical IgAN resolved within several weeks after engraftment into a patient with non-IgAN end-stage renal disease [25]; acute rejection may accelerate the process [26, 27]. The gene discussed is CD79A; the disease is stage 5 chronic kidney disease.